news
Elios Therapeutics: A Staff Writer's Overview
What Elios Therapeutics is working on, how its platform differs, and what to watch for next.
Every article on Detroit Bureau about Tumor Microenvironment — 2 stories covering it, newest first.
culture
CSF1 Inhibitor: Mechanism, Clinical Uses, and Resistance Considerations
A concise overview of CSF1 inhibitors, how they work, which cancers they treat, common side effects, and what drives resistance to these targeted therapies.
Topic